Outsourcing-pharma4h
Verdiva Bio launches with $411m in funds to advance oral and injectable drugs for obesity
Newly launched company, Verdiva Bio, is aiming to advance oral and injectable drugs for obesity, with it backed by an ...
Outsourcing-pharma6h
India’s Anthem Biosciences plans $397m IPO
As India’s contract manufacturing and development organization (CDMO) is set to double in the next decade, Anthem Biosciences ...
Outsourcing-pharma2d
Denali Therapeutics’ ALS drug fails to improve function and survival in phase 2/3 trial
Denali Therapeutics' DNL343 fails to slow ALS progression in phase 2/3 trial but shows safety and offers insights for future ...
Outsourcing-pharma3d
Orbis Medicines bags €90 million Series A to develop oral competitors of biologics
Orbis Medicines secures €90M Series A to develop innovative oral macrocycles, offering cost-effective alternatives to ...